|
|
Volumn 12, Issue 5, 1996, Pages 389-392
|
|
Comparative approach to retroviral vaccines
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
NEUTRALIZING ANTIBODY;
RECOMBINANT VACCINE;
SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;
VIRUS VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BOVINE LEUKEMIA VIRUS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNITY;
MONKEY;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RETROVIRUS;
RETROVIRUS INFECTION;
SEMLIKI FOREST ALPHAVIRUS;
SHEEP;
SIMIAN IMMUNODEFICIENCY VIRUS;
VACCINATION;
VACCINIA VIRUS;
|
|
EID: 0029879808
PISSN: 08892229
EISSN: None
Source Type: Journal
DOI: 10.1089/aid.1996.12.389 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
